Medicine Guidelines and Policies Group (MGPG)
The Medicine Guidelines and Policies Group (MGPG) appraise, ratify and approve Grampian policies, guidelines and protocols relating to medicines use. Whilst the group takes direction from the Grampian Medicines Management Group it is largely autonomous and generates its own work programme in conjunction with the Formulary Group. The role of the group is to ensure that the development and/or review of local Patient Group Directions (PGDs) and medicines guidance has been undertaken appropriately and where relevant, to provide direction for the implementation process. The MGPG will also identify and consider relevant national guidelines/guidance and policies containing advice in relation to medicine use and ensure referral to the appropriate group(s)/specialities to ascertain local impact. The majority of the work required to develop, implement or audit local guidelines, policies or protocols is undertaken by key individuals with specialist interests, short life working groups (SLWG) or individual departments external to the MGPG.
Remit of the MGPG
- Appraise and consider Grampian policies, guidelines, PGDs and protocols* containing advice in relation to medicine use providing feedback to aid clinical document development.
- Ratify and approve policies, guidelines and protocols* with a predominant medicines focus, ensuring appropriate clinical governance standards have been followed, and relevant national/local guidelines/polices/processes have been considered.
- Ratify and approve Patient Group Directions (PGDs) ensuring compliance with legislation, and that appropriate clinical governance standards, and relevant national guidelines/polices/processes have been considered.
- Interface with governance and medicines risk management groups to ensure that adequate and appropriate protocols are developed and maintained to minimise risk and harm in medicines usage.
- Where appropriate, request audit to be undertaken by specialist services/departments /SLWGs to ensure governance around medicines, guidelines, PGDs or policies.
- Request needs assessments to be undertaken by specialist services/ departments /SLWGs to ensure requests for specific medicines, guidelines, PGDs or policies are appropriate, e.g. PGD request form.
- Identify national guidelines and policies, e.g. Healthcare Improvement Scotland, NICE and SIGN, were medicines management implications may necessitate local policies, guidelines and protocols to be developed and refer to the appropriate speciality for consideration.
* Excluding departmental, ward or single service clinical process documents.
MGPG meets every six weeks.
Membership of the Medicine Guidelines and Policies Group
Chair - Dr Caroline Hind, Deputy Director of Pharmacy and Medicines Management
- GP representative - nominated by the GP Sub Committee
- Consultant representative - nominated by the Consultant Sub Committee of the AMC
- Secondary Care pharmacist
- Pharmacy and Medicines Directorate representative
- CHP Pharmacists - nominated by the CHP pharmacist group
- Clinical Governance - a nominee from the Clinical Governance Committee
- Nursing representative - nominated by the ANC
Formulary Manager to link with the Medicine Guidelines and Policies Group.
Nominated individuals, from the groups below, with open invite to attend meetings as they feel appropriate. Representatives will receive agendas and minutes and will be expected to communicate with the groups/bodies that they represent as well as the Medicine Guidelines and Policies group.
- Dental practitioners
- Community pharmacists (Chemist Contractors Committee)
- Public Health Consultant (with a special remit for pharmacy and medicines management)
Communication with the MGPG
All communications with the MGPG should be sent to:
The Secretary MGPG, Westholme, Woodend Hospital, Queens Road, Aberdeen. AB15 6LS.